Medications are an essential aspect of health care. The PharmacoEpidemiology & Drug Safety (PharmaSafe) research group covers a multitude of different research activities related to the safety and optimal use of medications, on both the individual and societal level. We are a multidisciplinary team of researchers, with expertise in a wide range of topics, including pharmacoepidemiology and drug safety, pharmaco(epi)genetics, biostatistics, health economics, and pharmacotherapy.
Using epidemiological methods, we address questions of drug safety that are challenging to study in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, examination of perceptions toward medications, methodology and health economic research, and analysis of medication safety on patient outcomes, including genetic and epigenetic contributions.
News
-
Sara Salvadori visits PharmaSafe! May 13, 2024 7:51 PM
Please join us in welcoming Sara Salvadori, who is visiting the PharmaSafe research group from Italy. Read on to hear more about her interests and background.
-
New Covid-19 publications from PharmaSafe Apr. 29, 2024 1:24 PM
PharmaSafe Research Group Contributes to Research on COVID-19 Vaccine Effectiveness in Preventing Long COVID
-
Liv Vidas joins PharmaSafe! Apr. 16, 2024 1:54 PM
Please join us in welcoming our newest PhD candidate, Liv Vidas! Read below for an introduction to her and her background.
-
New iAPOGEE guest researcher visits PharmaSafe! Apr. 15, 2024 9:17 AM
Takamasa Sakai, Assistant Professor at Meijo University in Japan, is visiting PharmaSafe research group for one year to work on a research project about the use of antipsychotics in pregnancy. Read on to hear more about his background.
-
Highlights of Our PharmaSafe Seminar! Apr. 2, 2024 3:39 PM
A Recap of Our Inspiring 2.5-Day Research Gathering
